Absorption |
Blood-Brain Barrier | BBB+ | 0.9396 |
Human Intestinal Absorption | HIA+ | 0.9933 |
Caco-2 Permeability | Caco2+ | 0.7888 |
P-glycoprotein Substrate | Non-substrate | 0.5921 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7377 |
Non-inhibitor | 0.9398 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7331 |
Distribution |
Subcellular localization | Mitochondria | 0.5396 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8362 |
CYP450 2D6 Substrate | Non-substrate | 0.8780 |
CYP450 3A4 Substrate | Non-substrate | 0.5866 |
CYP450 1A2 Inhibitor | Inhibitor | 0.5761 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9018 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9020 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.5458 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8199 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5891 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8353 |
Non-inhibitor | 0.9442 |
AMES Toxicity | Non AMES toxic | 0.8790 |
Carcinogens | Non-carcinogens | 0.7457 |
Fish Toxicity | High FHMT | 0.9777 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9985 |
Honey Bee Toxicity | High HBT | 0.7841 |
Biodegradation | Ready biodegradable | 0.9661 |
Acute Oral Toxicity | III | 0.8666 |
Carcinogenicity (Three-class) | Non-required | 0.5707 |